VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CSBRChampions Oncology, Inc.
$6.63$93M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksCSBRPrice History

CSBR logoChampions Oncology, Inc. (CSBR) Stock Price History

Historical prices from 2007 to 2026

$6.63+0.55  (+9.05%)close Jun 26
Returns
1M
+10.8%
3M
+14.5%
YTD
-0.5%
1Y
-8.2%
3Y
+3.4%
5Y
-8.9%
ATH$25.80Oct 2007-74.3%
ATL$1.11Aug 2016pre-split
Avg Vol (50D)9K/ day
52-Week Range$5.50 — $9.63
LowCurrent: $6.63High

Loading 10-year price history...

CSBR Historical Performance

1 YearTotal Return
-21.1%
Price: -8.2%
3 YearsTotal Return
+2.4%
CAGR: +0.8%
Price: +10.5%
5 YearsTotal Return
-36.5%
CAGR: -8.7%
Price: -37.4%
YTD
-0.5%

CSBR Annual Returns

Year-by-year price performance · 2007–2026

Best+300.0%2013
Worst-60.0%2012
Up years9/20
2007+133.3%
2008-20.0%
2009-25.9%
2010+12.5%
2011-16.7%
2012-60.0%
2013+300.0%
2014-58.3%
2015-40.5%
2016-33.1%
2017+36.1%
2018+94.3%
2019+5.6%
2020+32.6%
2021-22.6%
2022-46.8%
2023+27.1%
2024+48.0%
2025-15.7%
2026-10.6%
2007 annual price return
+133.3%
2008 annual price return
-20.0%
2009 annual price return
-25.9%
2010 annual price return
+12.5%
2011 annual price return
-16.7%
2012 annual price return
-60.0%
2013 annual price return
+300.0%
2014 annual price return
-58.3%
2015 annual price return
-40.5%
2016 annual price return
-33.1%
2017 annual price return
+36.1%
2018 annual price return
+94.3%
2019 annual price return
+5.6%
2020 annual price return
+32.6%
2021 annual price return
-22.6%
2022 annual price return
-46.8%
2023 annual price return
+27.1%
2024 annual price return
+48.0%
2025 annual price return
-15.7%
2026 annual price return
-10.6%
LessMore
Alpha vs S&P 500
1Y-41.9%
3Y-18.4%
5Y-18.6%

Price returns only.

Download Historical Data

4,875 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

CSBR Stock Price Trajectory (2007–2026)

As of June 28, 2026, Champions Oncology, Inc. (CSBR) trades at $6.63, representing a -8.2% return over the past year. The stock has delivered a -36.5% total return over five years (-8.9% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $25.80 on October 24, 2007. From this peak, CSBR has corrected -74.3%, currently trading 4% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers IMVT (+137.0% 1Y), CASI (-88.4% 1Y), and TPVG (-32.1% 1Y), CSBR has underperformed the peer group average. Compare CSBR vs IMVT →

CSBR Historical Price Data · from 2007

Rows 1–50 of 4,875
Date Open High Low Close Volume Change %
2026-06-266.016.636.016.6315K+9.05%
2026-06-256.326.325.866.086K-0.98%
2026-06-246.146.596.146.149K-1.44%
2026-06-236.446.446.176.234K-0.32%
2026-06-226.467.006.146.255K-1.11%
2026-06-186.726.766.316.325K-5.53%
2026-06-176.736.736.516.693K+2.92%
2026-06-166.346.506.146.5014K+2.52%
2026-06-156.476.496.296.349K-2.46%
2026-06-127.007.006.346.504K+1.25%
2026-06-115.786.645.716.4211K+12.24%
2026-06-105.906.075.725.722K-1.21%
2026-06-095.886.005.675.796K+2.66%
2026-06-085.615.755.605.648K-0.18%
2026-06-055.675.675.645.65725-1.91%
2026-06-045.735.765.715.761K+1.23%
2026-06-035.675.745.615.6913K-0.61%
2026-06-025.685.855.665.724K-1.97%
2026-06-015.755.845.665.8410K+0.09%
2026-05-295.925.925.835.8312K-0.26%
2026-05-285.905.945.755.8521K-0.34%
2026-05-275.985.985.835.875K-1.92%
2026-05-266.016.165.855.996K-0.42%
2026-05-225.766.115.766.0111K+1.01%
2026-05-215.936.005.755.9523K-1.65%
2026-05-205.996.105.936.058K+1.17%
2026-05-195.866.015.865.9816K-1.48%
2026-05-186.006.205.996.079K-2.10%
2026-05-156.356.356.206.203K-0.16%
2026-05-146.046.396.046.2114K+3.16%
2026-05-136.266.266.026.0213K-0.50%
2026-05-125.906.145.866.059K+0.67%
2026-05-116.006.015.836.0118K-0.17%
2026-05-086.006.305.846.0221K+0.50%
2026-05-076.006.005.865.9917K-4.77%
2026-05-066.006.306.006.2917K+5.36%
2026-05-055.926.005.915.972K+1.36%
2026-05-045.926.005.875.892K-1.67%
2026-05-015.926.005.905.997K+0.50%
2026-04-305.816.005.735.962K+1.88%
2026-04-295.855.855.855.85552-1.01%
2026-04-286.166.325.705.918K-1.83%
2026-04-275.786.335.786.0212K+2.64%
2026-04-246.046.045.805.871K-2.90%
2026-04-235.906.065.856.045K+0.50%
2026-04-225.926.105.796.018K+3.62%
2026-04-216.266.305.805.8013K-4.53%
2026-04-205.986.085.956.084K+0.66%
2026-04-175.986.085.986.041K-1.07%
2026-04-166.086.135.776.102K-1.29%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

CSBR — Frequently Asked Questions

Quick answers to the most common questions about buying CSBR stock.

How has CSBR stock performed recently?

CSBR declined -8.2% over the past year, below its 5-year annualized CAGR of -8.9%. The stock trades above its 200-day moving average, reflecting the downtrend.

What is CSBR's all-time high price?

Champions Oncology, Inc. reached $25.80 on 2007-10-24. The 52-week high is $9.63. Current 1-year return of -8.2% places the stock further from historical peaks.

Where can I download CSBR historical price data?

This page provides CSBR daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2007-2026, downloadable in CSV format.

489 data points · sampled from 4,875